New Recalls by Johnson & Johnson Raise Concern About Quality Control Improvements

  • Home
  • »
  • Blog
  • »
  • New Recalls by Johnson & Johnson Raise Concern About Quality Control Improvements

philadelphia personal injury lawyers | philadelphia personal injury attorneys | new jersey personal injury attorneys | new jersey personal injury lawyers
Photo via Wikipedia Commons
Philadelphia personal injury attorneys express concern about the recent product recalls announced by Johnson & Johnson after the company’s subsidiary, Janssen, informed doctors and patients that it would recall one lot of Risperdal Consta. The injectable antipsychotic drug showed evidence of mold after undergoing after routine testing. Johnson & Johnson also recalled 200,000 bottles of liquid Motrin for infants earlier this month indicating the bottles may contain tiny particles of plastic.

The recalls triggered questions about Johnson & Johnson’s oversight of companies who manufacture their products. Those questions have lingered since multiple issues in the company’s plants caused the pharmaceutical giant to recall several products over the last few years, including the popular over-the-counter drug Tylenol. At the urging of the Food and Drug Administration, Johnson & Johnson agreed to improve its manufacturing processes by overhauling three of its production plants. The company’s Fort Washington, Pa. plant has been closed since 2010.

Personal Injury Attorneys Say Johnson & Johnson’s Quality Control Problems a Factor in Tainted Tylenol Cases

McNeil, a subsidiary of Johnson & Johnson, has struggled with quality control problems since at least 2004. The company has admitted to a “stealth” recall of at least one product after it was found to be deficient. The company’s Fort Washington McNeil plant was repeatedly criticized by the FDA for its deficiencies and permanently closed in April 2010 when a recall was initiated after some of McNeil’s products were allegedly contaminated with foreign materials due to an equipment-cleaning problem.

McNeil has recalled at least 40 products manufactured at their plants over the last few years. The company was also responsible for the largest recall of children and infant medicine in history. The personal injury attorneys at Messa & Associates have filed three lawsuits against McNeil and its parent company, Johnson & Johnson, involving Tylenol. In all three cases, toddlers who ingested tainted Tylenol died as a result of liver failure.

New Jersey and Philadelphia Personal Injury Lawyers

The Philadelphia personal injury lawyers at Messa & Associates are experienced at handling cases involving pharmaceutical and drug product injuries. Our extremely skilled team of personal injury lawyers and medical experts is dedicated to ensuring you receive proper compensation for your personal injuries. If you have suffered liver damage as a result of a Tylenol, an injury related to the use of Motrin or another defective pharmaceutical drug product, or any other type of personal injury, contact the personal injury lawyers of Messa & Associates for a free consultation. Call toll free at 1-877-MessaLaw, or submit a free online inquiry.

WE CAN HELP!

Call the Philadelphia personal injury lawyers of Messa & Associates today to discuss your case with a professional who has the knowledge to answer your questions or submit a free online inquiry.

Call, toll-free, 1-877-MessaLaw (637-7252), or submit a free online inquiry form.

About the Author:

Director of Marketing for Messa & Associates located in Philadelphia, Pennsylvania. For all marketing or press release communications, contact sking@messalaw.com.

Leave a Reply

Your email address will not be published. Required fields are marked

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}